Bulk summary reports often fail to promptly spot potential safety signalsImprovements needed to safeguard patients and meet ...
TOKYO- Medical device maker Olympus Corporation has acknowledged receipt of a new Warning Letter from the U.S. Food and Drug ...
Medical Device Network on MSN
Olympus’ shares plunge following FDA warning letter over manufacturing failures
The FDA’s Warning Letter follows its completion of inspections at six of Olympus’ international manufacturing sites in late ...
From Hospital AI to Home Monitoring: Taiwan's Health-Tech Sector Tests Its U.S. Market Fit in Dallas
Taiwan's healthcare technology sector has no shortage of devices, AI models or clinical data. The harder question is what ...
Spontaneous reporting systems and clinical registries serve complementary purposes Medical devices often enter clinical ...
Japan Medical Biotechnology Limited has released information regarding its Newskin Whole Embryonic Layer Anti-Aging Skin ...
2d
People say these peptides hurt them. Their stories are muffled in MAHA’s push for medical freedom
Companies are required to warn that experimental peptides, which haven’t been approved by the FDA, are for research use only.
Leverage regulatory support, expanding real-world data and advanced analytics to accelerate approvals, strengthen safety monitoring and uncover new revenue streams.Dublin, Oct. 13, 2026 (GLOBE ...
Menstrual health wearable market to grow from USD 530.0 Mn in 2026 to USD 2,278.3 Mn by 2036 at a 15.7% CAGR. Get segment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results